Who owns Lumos Pharma Inc?
- CUSIP Number: 55028x109
Tip: Access positions for across all investors
Analyze quarterly positions in Lumos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Lumos Pharma stock
Who bought or sold Lumos Pharma Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Private Advisor | 745k | $2.9M | 2381% | Sep 2024 |
|
Renaissance Technologies | 214k | $828k | -1% | Sep 2024 |
|
Greenwich Wealth Management | 76k | $295k | 0% | Sep 2024 |
|
Wells Fargo & Company | 65k | $252k | -84% | Sep 2024 |
|
Geode Capital Management | 55k | $214k | 9% | Sep 2024 |
|
BlackRock | 40k | $154k | 100% | Sep 2024 |
|
Dimensional Fund Advisors | 25k | $98k | -15% | Sep 2024 |
|
Bank of New York Mellon | 12k | $46k | 0% | Sep 2024 |
|
Wealth Advisors of Iowa | 12k | $45k | 100% | Sep 2024 |
|
Key FInancial | 11k | $42k | 0% | Sep 2024 |
|
Paladin Advisory Group | 4.4k | $17k | 0% | Sep 2024 |
|
Bank of America Corporation | 1.8k | $7.0k | 0% | Sep 2024 |
|
West Financial Advisors | 784.00 | $3.0k | 0% | Sep 2024 |
|
Advisor Group Holdings | 290.00 | $1.1k | 100% | Sep 2024 |
|
Royal Bank of Canada | 50.00 | $0 | -36% | Sep 2024 |
|
Jpmorgan Chase & Co | 13.00 | $50.000600 | 0% | Sep 2024 |
|
Live Oak Investment Partners | 11.00 | $43.000100 | 0% | Sep 2024 |
|
Jones Financial Companies, L.L | 4.00 | $16.000000 | 100% | Sep 2024 |
|
Who sold out of Lumos Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Acuitas Investments | Jun 2024 | 141k | $328k |
Millennium Management | Jun 2024 | 37k | $86k |
Marquette Asset Management | Jun 2024 | 26k | $60k |
Envestnet Asset Management | Jun 2024 | 20k | $45k |
Citadel Advisors | Jun 2024 | 19k | $44k |
Atria Investments | Jun 2024 | 11k | $25k |
Redwood Wealth Management Group | Jun 2024 | 500.00 | $1.2k |